Passage Bio Inc. (NASDAQ: PASG) Stock Information | RedChip

Passage Bio Inc. (NASDAQ: PASG) Listen to this Section


$0.77
-0.0104 ( -1.33% ) 99.6K

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Market Data


Open


$0.77

Previous close


$0.78

Volume


99.6K

Market cap


$47.12M

Day range


$0.76 - $0.81

52 week range


$0.58 - $1.79

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 19, 2024
10-k Annual reports 89 Mar 04, 2024
8-k 8K-related 46 Mar 04, 2024
8-k 8K-related 14 Feb 29, 2024
4 Insider transactions 1 Feb 13, 2024
4 Insider transactions 1 Feb 13, 2024
8-k 8K-related 42 Jan 05, 2024
4 Insider transactions 1 Jan 03, 2024
4 Insider transactions 1 Jan 03, 2024
4 Insider transactions 1 Jan 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.